Drugmaker Sanofi SA will buy Amunix Pharmaceuticals Inc for an upfront payment of about $1 billion, marking the latest acquisition by the French drugmaker in the US biotech sphere as Sanofi aims to offset Covid-19 vaccine setbacks. Sanofi, under pressure to revive its drug pipeline and eager to overcome setbacks in the Covid-19 vaccine race, added on Tuesday that it will also